Portfolio news & events - Archives
Blueprint Medicines
January 24, 2012 - Blueprint Medicines Appoints Oncology Drug Development Leader Christoph Lengauer as Chief Scientific Officer
» Press Release | Company News
Constellation Pharmaceuticals
January 17, 2012 - Constellation Pharmaceuticals and Genentech Enter Broad Epigenetics Drug Discovery Collaboration
» Press Release | Company News
Ember Therapeutics
January 12, 2012 -
Ember Therapeutics Announces Nature Publication of Brown Fat Biology Data; Program Exclusively Licensed from the Dana-Farber Cancer Institute
» Press Release | Company News
Foundation Medicine
January 10, 2012 - Foundation Medicine Announces Collaboration with Sanofi
» Press Release | Company News
WarpDrive Bio
January 10, 2012 - Third Rock Ventures and Sanofi Announce Launch of
Warp Drive Bio; Broad Strategic Partnership Builds Innovative Genomics Search Engine to Reveal Nature’s Drugs
» Press Release
NinePoint Medical
January 5, 2012 -
NinePoint Medical Receives FDA 510(k) Clearance for Nvision VLE Imaging System
» Press Release | Company News
Seventh Sense Biosystems
December 16, 2011 -
Seventh Sense Biosystems Receives $3.28 Million Grand Challenges Point-of-Care Diagnostics Grant to Expand Touch Activated Phlebotomy™ Technology Platform
» Press Release | Company News
Ember Therapeutics
December 15, 2011 -
Third Rock Ventures Launches Ember Therapeutics to Address Critical Need for Novel Treatments for Metabolic Disease
» Press Release | Company News
Rhythm
November 30, 2011 -
Rhythm Names Lex Van der Ploeg Chief Scientific Officer
» Press Release | Company News
Sage Therapeutics
November 30, 2011 - SAGE Therapeutics Appoints Chief Scientific Officer, Strengthens Management Team
» Press Release | Company News
TARIS Biomedical
November 30, 2011 - TARIS Initiates Phase 2 Clinical Study with LiRIS in Interstitial Cytitis Patients
» Press Release | Company News
Agios Pharmaceuticals
November 17, 2011 -
Agios Secures $78 Million in Oversubscribed Series C Financing
» Press Release | Company News
Allena
November 16, 2011 - Allena Pharmaceuticals Launches with $15 Million Series A Round
» Press Release | Company News
Rhythm
November 9, 2011 - Rhythm Names Keith M. Gottesdiener Chief Executive Officer
» Press Release | Company News
Foundation Medicine
November 2, 2011 - Foundation Medicine Appoints Medical Oncologist Vincent A. Miller, M.D., as Senior Vice President of Clinical Development
» Press Release | Company News
Foundation Medicine
October 25, 2011 - Foundation Medicine Announces Fourth Major Pharmaceutical Alliance
» Press Release | Company News
NinePoint Medical
October 25, 2011 -
NinePoint Medical Announces New Data Presented on Innovative Optical Frequency Domain Imaging Technology at 19th UEGW Meeting
» Press Release | Company News
Foundation Medicine
October 18, 2011 - Foundation Medicine Closes Expanded Series A Financing Totaling $33.5 Million; Kleiner Perkins Caufield & Byers and Google Ventures Join as Investors
» Press Release | Company News
SAGE Therapeutics
October 19, 2011 - Ligand Enters into Platform Captisol(R) License Agreement with SAGE Therapeutics
» Press Release | Company News
Foundation Medicine
October 18, 2011 - Foundation Medicine Closes Expanded Series A Financing Totaling $33.5 Million; Kleiner Perkins Caufield & Byers and Google Ventures Join as Investors
» Press Release | Company News
TOPICA Pharmaceuticals
October 18, 2011 - TOPICA Announces Completion of $27 Million Series B Financing
» Press Release | Company News
SAGE Therapeutics
October 18, 2011 - Third Rock Ventures Launches SAGE Therapeutics to Address CNS Disorders with Critical Unmet Needs
» Press Release | Company News
Zagfen, Inc.
October 13, 2011 - Zafgen Appoints Business Development Veteran Frances K. Heller to Board of Directors
» Press Release | Company News
CytomX Therapetutics
October 6, 2011 -
CytomX Therapeutics Promotes Henry Lowman, Ph.D., to Chief Scientific Officer
» Press Release | Company News
Agios Pharmaceuticals
October 5, 2011 -
Celgene and Agios Extend Cancer Metabolism Collaboration
» Press Release | Company News
Zagfen, Inc.
September 28, 2011 - Zafgen to Present at The Obesity Society 29th Annual Scientific Meeting
» Press Release | Company News
Constellation Pharmaceuticals
September 26, 2011 - Constellation Pharmaceuticals Announces Publication Demonstrating Pharmacological Suppression of Key Cancer-causing Gene
» Press Release | Company News
Foundation Medicine
September 22, 2011 - Data on Foundation Medicine’s Comprehensive Cancer Diagnostic Test Presented at 2011 European Multidisciplinary Cancer Congress
» Press Release | Company News
Eleven Biotherapeutics
September 22, 2011 - Eleven Biotherapeutics Appoints Abbie Celniker, Ph.D., Chief Executive Officer; Chen Schor Joins as Chief Business Officer
» Press Release | Company News
Zagfen, Inc.
September 21, 2011 - Zafgen Appoints Industry Executive Dennis Kim, M.D., M.B.A., to Chief Medical Officer
» Press Release | Company News
Agios Pharmaceuticals
September 20, 2011 -
Marc Tessier-Lavigne, Ph.D., President of The Rockefeller University, Joins Agios Board of Directors
» Press Release | Company News
August 2, 2011 -
Agios Founder and Advisor Publish In Nature Genetics On Further Links Between Serine Metabolic Pathway and Cancer
» Press Release | Company News
Rhythm
July 26, 2011 - Rhythm Expands Scientific Advisory Board for Clinical Programs in Metabolic Diseases
» Press Release | Company News
Taris Biomedical
July 25, 2011 - TARIS Appoints Christopher Searcy as the Company’s Chief Business Officer
» Press Release | Company News
Agios Pharmaceuticals
July 14, 2011 - Agios and Whitehead Institute Collaborate on Nature Publication Revealing Altered Metabolic Pathway in Breast Cancer
» Press Release | Company News
Zagfen, Inc.
July 7, 2011 - Zafgen Secures $33 Million Series C Financing - Proceeds to Advance Zafgen’s Lead Compound for Severe Obesity into Phase 2 Clinical Studies
» Press Release | Company News
Lotus Tissue Repair, Inc.
June 30, 2011 - Lotus Tissue Repair, Inc. Secures $26 Million Series A Financing to Develop First-in-Class Protein Replacement Therapy for Dystrophic Epidermolysis Bullosa
» Press Release | Company News
Zagfen, Inc.
June 24, 2011 - Zafgen Announces Cardiovascular Data from Phase 1b Study of ZGN-433 in Obesity at American Diabetes Association Annual Meeting
» Press Release | Company News
Foundation Medicine
June 22, 2011 - Foundation Medicine to Present Data on Next-Generation Sequencing Approach to Cancer Genome Analysis at Several Upcoming Industry Conferences
» Press Release | Company News
June 16, 2011 - Foundation Medicine Appoints Kevin Krenitsky, M.D., as Chief Operating Officer
» Press Release | Company News
June 6, 2011 - Foundation Medicine Announces Results Using Next-Generation Sequencing to Detect Cancer-Associated Mutations in Routine Cancer Tissue Samples; Data Presented at ASCO
» Press Release | Company News
Ablexis
June 15, 2011 -
Ablexis Appoints Jake Bauer as Senior Director, Corporate Development and Business Operations
» Press Release | Company News
Constellation Pharmaceuticals
June 6, 2011 - Constellation Pharmaceuticals Raises $15 Million in Additional Funding
» Press Release | Company News
Foundation Medicine
May 19, 2011 - Foundation Medicine to Present New Data on its Comprehensive Cancer Genomic Test at ASCO 2011 Annual Meeting
» Press Release | Company News
May 17, 2011 -
Foundation Medicine Announces Clinical Cancer Genomics Collaboration with Celgene
» Press Release | Company News
bluebird bio
May 16, 2011 - bluebird bio Adds Biotech Industry Veterans to Management Team and Board
» Press Release | Company News
Foundation Medicine
May 12, 2011 -
Foundation Medicine Board of Directors Appoints Michael J. Pellini, M.D., President and Chief Executive Officer
» Press Release | Company News
Seventh Sense Biosystems
May 11, 2011 - Seventh Sense Biosystems Secures $4.5 Million of Two-Tranche $10 Million Extension of its Series A Financing
» Press Release | Company News
Rhythm
May 9, 2011 - Rhythm's RM-131 Restores GI Function as a Potent Ghrelin Prokinetic
» Press Release | Company News
bluebird bio
April 20, 2011 - bluebird bio Secures Additional $30 Million in Financing; ARCH Venture Partners Joins Investor Team
» Press Release | Company News
Taris Biomedical
April 13, 2011 - Taris Closes $18.3 Million Series B Financing - Third Rock Ventures Leads Round
» Press Release | Company News
Blueprint Medicines
April 11, 2011 - Blueprint Medicines Secures $40 Million Series A Financing to Translate New Molecular Data into Personalized Cancer Treatments
» Press Release | Company News
bluebird bio
March 21, 2011 - bluebird bio Appoints World Leading Experts to Inaugural Scientific Advisory Board
» Press Release | Company News
March 17, 2011 - bluebird bio Appoints Alexandre P. LeBeaut, M.D., as Chief Medical Officer
» Press Release | Company News
March 16, 2011 -
bluebird bio Awarded up to $4.2 Million from the French Muscular Dystrophy Association for Continued Development of Gene Therapy for Beta-Thalassemia and Sickle Cell Anemia
» Press Release | Company News
Constellation Pharmaceuticals
February 1, 2011 - Constellation Pharmaceuticals Expands Leadership Team with Drug Development Industry Veterans
» Press Release | Company News
Afferent Pharmaceuticals
January 26, 2010 - Afferent Pharmaceuticals Names Bruce G. McCarthy, M.D., as CEO
» Press Release | Company News
Foundation Medicine
January 19, 2011 -
Foundation Medicine Appoints Gary Palmer, M.D., as Senior Vice President of Medical Affairs and Commercial Development
» Press Release | Company News
Agios Pharmaceuticals
January 6, 2011 -
Agios Pharmaceuticals to Present at 29th Annual J.P. Morgan Healthcare Conference
» Press Release | Company News
Eleven Biotherapeutics
January 6, 2011 - Eleven Biotherapeutics Appoints Eric Furfine, Ph.D., to President of Research and Development
» Press Release | Company News
CytomX Therapeutics
January 5, 2011 - CytomX Therapeutics Appoints Sean McCarthy as Chief Business Officer
» Press Release | Company News
NinePoint Medical
January 5, 2011 - NinePoint Medical Adds Optical Coherence Tomography Technology Expert to Board of Directors
» Press Release | Company News
Zagfen, Inc.
January 5, 2011 - Zafgen Announces Positive Topline Phase 1b Data for ZGN-433 in Obesity
» Press Release | Company News
Foundation Medicine
January 4, 2011 - Foundation Medicine Announces First Large Pharmaceutical Company Collaboration
» Press Release | Company News
PanOptica
January 4, 2011 - PanOptica Raises $30 Million in Series A Financing and Licenses Lead Compound for Development as Topical Treatment of AMD
» Press Release | Company News
